Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

被引:74
|
作者
Warnecke, Tobias [1 ]
Suttrup, Inga [1 ]
Schroeder, Jens B. [1 ]
Osada, Nani [2 ]
Oelenberg, Stephan [1 ]
Hamacher, Christina [1 ]
Suntrup, Sonja [1 ]
Dziewas, Rainer [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, Dept Med Informat, Domagkstr 9, D-48149 Munster, Germany
关键词
Parkinson's disease; Dysphagia; Swallowing; FEES; Levodopa responsiveness; DOPAMINERGIC STIMULATION; SWALLOWING ABNORMALITIES; AGREEMENT; DIAGNOSIS; THERAPY;
D O I
10.1016/j.parkreldis.2016.04.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is still controversially discussed whether central dopaminergic stimulation improves swallowing ability in Parkinson's disease (PD). We evaluated the effect of oral levodopa application on dysphagia in advanced PD patients with motor fluctuations. Methods: In 15 PD patients (mean age 71.93 +/- 8.29 years, mean disease duration 14.33 +/- 5.94 years) with oropharyngeal dysphagia and motor fluctuations endoscopic swallowing evaluation was performed in the off state and on state condition following a specifically developed protocol (FEES-levodopa-test). The respective dysphagia score covered three salient parameters, i.e. premature spillage, penetration/aspiration events and residues, each tested with liquid as well as semisolid and solid food consistencies. An improvement of >30% in this score indicated levodopa responsiveness of dysphagia. Measures were compared between the off-and on-state condition by using the Wilcoxon Test and marginal homogeneity test. Inter- and intrarater reliability was also investigated. Results: Severity of swallowing dysfunction in the off state varied widely. The lowest dysphagia score was 15 points (dysphagia without any aspiration risk). The highest dysphagia score was 84 points (dysphagia with aspiration of all consistencies). Seven patients showed a marked improvement of dysphagia in the on state condition. Eight PD patients did not respond. Inter- and intrarater reliability was excellent for all three subscales in the off state and on state conditions. Conclusions: A significant proportion of advanced PD patients with motor fluctuations and mild to moderate oropharyngeal dysphagia may demonstrate a clinically relevant improvement of swallowing after levodopa challenge. The FEES-levodopa-test is a reliable and sensitive tool to differentiate these responders from non-responders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [41] Morphologic brain network predicts levodopa responsiveness in Parkinson disease
    Xie, Yongsheng
    Gao, Chunyan
    Wu, Bin
    Peng, Liling
    Wu, Jianjun
    Lang, Liqin
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 14
  • [42] Long Duration Response to Levodopa in Advanced Parkinson Disease
    Nieto, P.
    Garcia, A.
    Martin, I.
    Ibanez, R.
    Cabello, J. P.
    Vaamonde, J.
    MOVEMENT DISORDERS, 2023, 38 : S636 - S636
  • [43] Bromocriptine/levodopa combined versus levodopa alone forearly Parkinson's disease
    van Hilten, J. J.
    Ramaker, C. C.
    Stowe, R. L.
    Ives, N. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
  • [44] Abnormal temporal discrimination threshold and its responsiveness to levodopa treatment in Parkinson's disease
    Lee, M
    Kim, H
    Lyoo, C
    Kim, J
    MOVEMENT DISORDERS, 2004, 19 : S134 - S134
  • [45] Levodopa and the progression of Parkinson's disease - Reply
    Fahn, S
    Keiburtz, K
    Tanner, CM
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13): : 1386 - 1386
  • [46] Levodopa for Parkinson's Disease Reply.
    LeWitt, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 936 - 936
  • [47] Optimisation of treatment of Parkinson's disease with levodopa
    Bialecka, Monika
    Adamiak, Urszulo
    Gawronska-Szklarz, Barbara
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2009, 43 (05) : 446 - 459
  • [48] Initiating Levodopa Therapy for Parkinson's Disease
    Olanow, C. Warren
    Kieburtz, Karl
    Stocchi, Fabrizio
    MOVEMENT DISORDERS, 2014, 29 (03) : 430 - 430
  • [49] Levodopa motor complications in Parkinson's disease
    Obeso, JA
    Olanow, CW
    Nutt, JG
    TRENDS IN NEUROSCIENCES, 2000, 23 (10) : S2 - S7
  • [50] Unmasking levodopa resistance in Parkinson's disease
    Nonnekes, Jorik
    Timmer, Monique H. M.
    de Vries, Nienke M.
    Rascol, Olivier
    Helmich, Rick C.
    Bloem, Bastiaan R.
    MOVEMENT DISORDERS, 2016, 31 (11) : 1602 - 1609